
FDA commissioner talks of shortening drug approval process, benefits of AI
Food and Drug Administration Commissioner Marty Makary, M.D., spoke about the need to shorten the length of the drug approval process and the use of artificial intelligence, among other topics, during the AHA Annual Membership Meeting. “We at the FDA now …